All In MedTech

Device Trial Radar · NCT03291743

The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives

Last checked: Nov 19, 2026Latest source record: Dec 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

38

Actual

Start

Feb 10, 2017

Primary completion

Sep 30, 2022

Study completion Sep 30, 2022

Sponsor

Lead sponsor
Carilion ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 25, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Pursuing very early diagnosis is standard of care for several diseases including colon cancer, diabetes and liver disease where an early and aggressive diagnostic and therapeutic approach has been shown to change their natural history. Crohn's disease \[CD\] still lags since commonly at presentation CD has already run a long course, often responding poorly to therapy or requiring surgery. This innovative project proposes a minimally invasive strategy - capsule endoscopy-based screening of first degree relatives \[FDR's\] of CD patients - to develop tools to diagnose CD at or near its biologic onset.

Conditions

  • Crohn Disease
  • Genetic Predisposition
  • IBD

Interventions

  • Capsule endoscopyDevice

    PillCam(TM) CROHN'S CAPSULE

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Prevalence of Crohn's Disease in First Degree Relatives by capsule endoscopy screeningTime frame: coincident at screening

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Carilion Clinic

    Roanoke, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.